Guangxi Liuzhou Pharm Co Ltd Capital Reinvestment Ratio
Guangxi Liuzhou Pharm Co Ltd capital reinvestment ratio. Guangxi Liuzhou Pharm Co Ltd (603368) has a Capital Reinvestment Ratio of 0.81x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥45.64 Million) in capital expenditures (CN¥36.80 Million). See free cash flow generation of Guangxi Liuzhou Pharm Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Guangxi Liuzhou Pharm Co Ltd (2011–2024)
Capital reinvestment ratio of Guangxi Liuzhou Pharm Co Ltd from 2011 to 2024. This chart tracks Guangxi Liuzhou Pharm Co Ltd's Capital Reinvestment Ratio across 11 annual periods. See financial agility of Guangxi Liuzhou Pharm Co Ltd to measure the company's free cash flow as a share of total liabilities.
Guangxi Liuzhou Pharm Co Ltd Capital Reinvestment Ratio by Year (2011–2024)
Guangxi Liuzhou Pharm Co Ltd capital reinvestment ratio by year from 2011 to 2024. For the full cash flow conversion analysis, see 603368 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.18x | CN¥838.51 Million | CN¥147.87 Million | ▼ -39.4% |
| 2023 | 0.29x | CN¥594.41 Million | CN¥172.94 Million | ▼ -19.6% |
| 2022 | 0.36x | CN¥506.43 Million | CN¥183.28 Million | ▼ -54.4% |
| 2021 | 0.79x | CN¥332.88 Million | CN¥264.04 Million | ▲ +101.4% |
| 2020 | 0.39x | CN¥664.69 Million | CN¥261.81 Million | ▼ -34.8% |
| 2019 | 0.60x | CN¥412.91 Million | CN¥249.54 Million | ▼ -95.0% |
| 2018 | 12.18x | CN¥22.30 Million | CN¥271.61 Million | ▲ +936.7% |
| 2016 | 1.17x | CN¥108.39 Million | CN¥127.33 Million | ▼ -64.7% |
| 2013 | 3.33x | CN¥22.33 Million | CN¥74.31 Million | ▲ +1472.1% |
| 2012 | 0.21x | CN¥60.51 Million | CN¥12.81 Million | ▼ -23.2% |
| 2011 | 0.28x | CN¥133.38 Million | CN¥36.78 Million | — |